This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fuso Pharmaceutical Industries, Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Norihiko Sugimoto: Innovator in Nucleic Acid Detection
Introduction
Norihiko Sugimoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of nucleic acid detection, showcasing his expertise through innovative methodologies and devices.
Latest Patents
Sugimoto holds a patent for a "Nucleic acid detection or quantification method using mask oligonucleotide, and device for same." This invention enables very simple and highly sensitive detection or quantification of target nucleic acids. The method involves hybridizing mask oligonucleotides to specific regions in a single-stranded nucleic acid, which stabilizes the target while allowing for effective probe hybridization. This technique is further enhanced by subjecting the nucleic acid to chromatography, resulting in improved detection capabilities.
Career Highlights
Sugimoto is associated with Fuso Pharmaceutical Industries, Ltd., where he applies his innovative techniques to advance the field of molecular diagnostics. His work has garnered attention for its potential applications in various medical and research settings.
Collaborations
Some of his notable coworkers include Souji Eda and Masahiro Asakura, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Norihiko Sugimoto's contributions to nucleic acid detection represent a significant advancement in the field, highlighting the importance of innovation in medical diagnostics. His work continues to influence research and applications in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile